Last reviewed · How we verify
NCT03881657
Reverse Colocated Integrated Care Intervention Among Persons With Severe Persistent Mental Illness at US-Mexico Border
NA trial testing Reverse Colocated Integrated Care in Mental Illness Persistent in 416 participants. Completed in 22 August 2017.
22 August 2017
Quick facts
| Lead sponsor | Health Resources in Action, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 416 |
| Start date | 24 November 2015 |
| Primary completion | 22 August 2017 |
| Estimated completion | 22 August 2017 |
Drugs / interventions tested
- Reverse Colocated Integrated Care
- Usual Care
Conditions studied
- Mental Illness Persistent — all drugs for Mental Illness Persistent →
- Chronic Disease — all drugs for Chronic Disease →
- Hypertension — all drugs for Hypertension →
- Diabetes — all drugs for Diabetes →
Sponsor
Health Resources in Action, Inc.
Who can join
18 and older, any sex, with Mental Illness Persistent or Chronic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluated whether patients with severe and persistent mental illness (SPMI) who received coordinated co-located behavioral health and primary care services were more likely to improve health outcomes after 12 months compared to SPMI patients who receive only behavioral health services from the local mental health authority (LMHA) Tropical Texas Behavioral Health (TTBH).The study employed a randomized control trial (RCT) design where intervention participants receiving integrated behavioral health were compared to control participants receiving the usual care provided within an LMHA for SPMI patients. Patients were placed in each group using a randomized number process. Demographic and health outcome data were collected from intervention and control participants at baseline. Health outcome data was subsequently collected at 6-month and 12-month follow-up points.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Collaborative care approaches for people with severe mental illness.
Reilly S, Hobson-Merrett C, Gibbons B, Jones B, et al · · 2024 · cited 13× · PMID 38712709 · DOI 10.1002/14651858.cd009531.pub3 -
Randomized Trial of Reverse Colocated Integrated Care on Persons with Severe, Persistent Mental Illness in Southern Texas.
Errichetti KS, Flynn A, Gaitan E, Ramirez MM, et al · · 2020 · cited 9× · PMID 32314132 · DOI 10.1007/s11606-020-05778-2 -
A reverse colocated integrated care model intervention among persons with severe persistent mental illness at the U.S.-Mexico border: A randomized controlled trial protocol.
Sautter Errichetti K, Ramirez MM, Flynn A, Xuan Z. · · 2019 · cited 4× · PMID 31872157 · DOI 10.1016/j.conctc.2019.100490
Verify or expand the search:
- PubMed search for NCT03881657
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Health Resources in Action, Inc. trials
Trials by the same sponsor.
- NCT03916016 — Sí Texas Hope Family Health Center · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03881657 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Health Resources in Action, Inc.
- Last refreshed: 19 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03881657.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing